(Q38587587)

4 September 2017

title

Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective (English)

1 reference

4 September 2017

Paula Salmikangas

1

1 reference

4 September 2017

Martina Schuessler-Lenz

2

1 reference

4 September 2017

Sol Ruiz

3

1 reference

4 September 2017

Patrick Celis

4

1 reference

4 September 2017

Ilona Reischl

5

1 reference

4 September 2017

Margarida Menezes-Ferreira

6

1 reference

4 September 2017

Egbert Flory

7

1 reference

4 September 2017

Matthias Renner

8

1 reference

4 September 2017

Nicolas Ferry

9

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 January 2015

1 reference

Advances in Experimental Medicine and Biology

4 September 2017

published in

1 reference

4 September 2017

volume

871

1 reference

4 September 2017

page(s)

103-130

1 reference

Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18618-4_6

The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18618-4_6

Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18618-4_6

CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18618-4_6

Progress in gene therapy for primary immunodeficiencies using lentiviral vectors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18618-4_6

Development of novel treatment options for patients with haemophilia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18618-4_6

Clinical development of advanced therapy medicinal products in Europe: evidence that regulators must be proactive

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18618-4_6

10.1007/978-3-319-18618-4_6

31 March 2020

Identifiers

DOI

1 reference

4 September 2017

1 reference